<DOC>
	<DOC>NCT00411294</DOC>
	<brief_summary>To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4</brief_summary>
	<brief_title>Ergocalciferol in Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>Patient with CKD stage 3 or 4 whose 25hydroxyvitamin D levels are below 30 ng/ml and plasma intact PTH levels &gt;70 pg/ml. Patients who are on any form of active vitamin treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>ergocalciferol</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>secondary hyperparathyroidism</keyword>
	<keyword>vitamin D deficiency</keyword>
</DOC>